Lithium sulphate - Karo PharmaAlternative Names: Lithionit
Latest Information Update: 21 Dec 2016
At a glance
- Originator BioPhausia
- Developer Karo Pharma AB
- Class Alkali metals; Antidepressants; Antimanics; Antipsychotics; Light metals
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Manic episodes